| Objective To compare and analyze the clinical efficacy of the staged versus the simultaneous bilateral hip joint replacement. Methods From Jan 2011 to Jan 2014, sixty patients ever treated with hip joint replacement in our hospital were selected as the research objects, and were equally divided into the staged group and the simultaneous group by random number table method. The blood loss, operation time, levels of C-reactive protein (CRP) and D-Dimer, postoperative complications and joint function between the two groups were observed and compared. Results The simultaneous group had lower intraoperative blood loss and shorter operation time than the staged group, and their differences were statistically significant (P<0.05), but there was no significant difference in the preoperative and postoperative Harris scores between the two groups (P>0.05). After replacement operation, the CRP levels of patients in the simultaneous group were significantly higher than those in the staged group (P<0.05), and such complications as deep vein thrombosis and infection occurred in the two groups were not significantly different (P>0.05). Conclusion The simultaneous bilateral hip joint replacement has an advantage of lower intraoperative blood loss and shorter hospitalization time, when compared with the staged bilateral hip joint replacement. |
